ACOR

Acorda Therapeutics, Inc.
ACOR

Overview Fund Activity
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

171 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 63 reducing their positions, and 29 closing their positions.

Holders
171
Holders Change
-10
Holders Change %
-5.52%
% of All Funds
4.57%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
58
Reduced
63
Closed
29
Calls
$14.5M
Puts
$21.5M
Net Calls
-$7.08M
Net Calls Change
+$9.66M

Top Buyers

1
SCM
1
Scopia Capital Management
New York
$87.8M
2
BC
2
Broadfin Capital
New York
$12.6M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$15M
4
Citadel Advisors
4
Citadel Advisors
Florida
$12.2M
5
Goldman Sachs
5
Goldman Sachs
New York
$15.1M

Top Sellers

1
DM
1
Deerfield Management
New York
$3.37M
2
Macquarie Group
2
Macquarie Group
Australia
$12.7M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$16.7M
4
Prudential Financial
4
Prudential Financial
New Jersey
$2.02M
5
Millennium Management
5
Millennium Management
New York
$5.18M
Name Market Value Shares Shares
Change 		Shares
Change %
SM
201
Sabby Management
Florida
– – – –
FO
202
FT Options
Illinois
– – – –
Susquehanna International Group
203
Susquehanna International Group
Pennsylvania
– – – –
WAM
204
Wolverine Asset Management
Illinois
– – – –
5 6 7 8
9